The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions

NCT03216278 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects in Fasted and Fed State

Interventions

DRUG: Dapagliflozin/metformin XR 5/500mg
DRUG: Dapagliflozin/metformin XR 5/500 mg
DRUG: Dapagliflozin/metformin XR 5/500mg
DRUG: Dapagliflozin/metformin XR 5/500mg
DRUG: Dapagliflozin/metformin XR 10/1000mg
DRUG: Dapagliflozin/metformin XR 10/1000mg
DRUG: Dapagliflozin/metformin XR 10/1000mg
DRUG: Dapagliflozin/metformin XR 10/1000mg

Sponsor

AstraZeneca